Andreia Ferreira
August 29, 2022

Annex 1 - Manufacture of Sterile Medicinal Products

Later last week, the new Annex 1 “Manufacture of Sterile Medicinal Products” has been published and our team has scrutinized the new guidance and their main changes.

As always, count with us for the implementation of this new document, namely through:

     •    Preparation and implementation of the Contamination Control Strategy; 

     •    Training on the new annex and the main changes; 

     •    Gap assessment between your company practice and the new annex requirements.   

Don´t forget that new requirements are to be implemented until 25/08/2023!

To access the guideline, follow this website: https://owlpharma-25787080.hubspotpagebuilder.eu/annex1

Contact us at owlpharma@owlpharma.pt for further information and queries!

Latest news

May 20, 2024

/

Gustavo Sousa

Handling API manufacturers: Insights from the New CEFIC-APIC Guide and Owlpharma recent experience

May 17, 2024

/

André Luz

Fórum de Diretores Técnicos de Distribuição

April 29, 2024

/

Verónica Pinho

New MDCG guidance: Investigator’s Brochure and Summary of Safety and Performance Template